Are you using the best research tools to understand your market? Are your data reliable and is your sample representative? 
FactPlusTM is a reality-based patient records study. It can help you assess market growth potential with much more precision than other methodologies; identify hidden growth opportunities in a new/ existing market (e.g., off label usage for target drug); and improve forecasting accuracy with respect to costs, revenue potential, and profitability. This study is necessary to understand such factors as dosing and titration (by diagnosis, duration of treatment), switching behaviors/ patterns, and patient characteristics. 
   

Is your product an injectable drug that is soon to be launched or that is currently competing in a highly dynamic market?

Do you have an accurate and reliable system for tracking changes in post-launch patient usage/ market share of your drug vs. each competitor?

Tracker PlusTM is a reality-based patient records product providing accurate metrics related to effects on market share of 

§         the volume of and also

§         the kinds of patients

receiving your drug and each competitor drug.

Tracker PlusTM looks at the facts while also capturing important physician perceptions.  It provides accurate measures of changing physician “mind share” for your drug and for each key competitor drug.

 Tracker PlusTM could be expanded periodically to gain insights into newly emerged issues such as

 

§         the major factors that promote or drive volume changes

§         effects on market share of  bundling/rebates/discounts by competitors

§         effects on market share of usage factors such as dosing and suitability for specific sites or patient conditions

 Tracker PlusTM study rounds can be conducted monthly, quarterly, or semiannually.  The frequency can be increased or decreased as market needs permit.

     

Are there gaps in your primary annual research? Are you aware of a bias in your data, but unsure how that bias affects results?
RealityCheckTM is a product used on an as needed basis. This product increases your ROI on your primary sources of annual research. This product determines biases, fills in gaps, and expands insight into your primary annual research (Internet studies, ATU studies, panel, or other nonrepresentative/ convenience sampling).  
   

 Do all of your research projects together yield ONE cohesive story? Does your ATU study disagree in some areas with your Chart audit/ patient records study?

The Problem: Pharmaceutical companies often purchase separate ATU and patient records research. Thus, they receive two outputs, a subjective study and a factual patient records study. Often, a conflict exists between what physicians perceive they do versus what they actually do. This is not to say that physicians intentionally misrepresent their actions. Instead physician decisions are often unconscious and derived from experience, knowledge, and habit. It is impossible to “correct” a perceptual questionnaire without the aid of a fact-based patient records study. Thus, physician perception and patient reality are often at odds, disabling both valid studies.  

The Solution: FactOp, the only product of its kind, is designed to give you the complete picture of your marketplace by obtaining 1) facts through patient records research, 2) participant opinion through a “sister” ATU study, and 3) the difference between “reality” and perception.

   Conducting both studies with the same firm using the same physicians enables better marketing strategies and a greater understanding of physicians. 

Examples of benefits are: 

  • Further uncover the differences in characteristics of physicians who are heavy prescribers of competitor drugs  

  • More easily integrate data from the primary research conducted by a company with APLD and the myriad other secondary data purchased by a client company.

  • Enhanced forecasting

  • Understand "today" through a factual patient records study

  • Forecast the changing dynamics of tomorrow through ATU/ perceptual research

 

© 2009 Clarity Pharma Research, LLC. All Rights Reserved.